Columbia University DKV | New York Academy of Sciences | Mailman School of Public Health | NIAID

Home

Feedback | About | Print | Help

Browse by speaker... --------------------------- Paul Masters Kathryn V. Holmes Linda Saif Thomas Ksiazek Panel 1 Discussion Larry Anderson Donald Low Chen Zhu Panel 2 Discussion David Ho Frederick Hayden Catherine Laughlin C. Richter King Thomas Monath Panel 3 Discussion C.J. Peters Marcelle Layton John La Montagne Panel 4 Discussion Latest Headlines Executive Summary Topics and Speakers Coronavirus Biology and Pathogenesis On the Front Lines Approaches to Vaccines and Drug Development Future Perspectives on Emerging Infections References and Resources Conference Transcript Conference Highlights

Topics and Speakers Research Report SARS Aetiology: A Research Update from Malik Peiris Welcome Ellis Rubinstein, Chief Executive Officer, New York Academy of Sciences Introductory Remarks W. Ian Lipkin, Director of the Center for Immunopathogenesis and Infectious Diseases, Mailman School of Public Health, Columbia University, New York Session I: Coronavirus Biology and Pathogenesis Moderated by Scott Hammer Speakers Paul Masters, Wadsworth Center, NY State Dept. of Health, Albany Molecular Biology of Coronaviruses Kathryn V. Holmes, Department of Microbiology, University of Colorado Health Sciences Center, Denver Coronavirus Pathogenesis Linda Saif, Professor, Food Animal Health Research Program, Ohio State University, Wooster Coronavirus Transmission and Persistence Thomas Ksiazek, Centers for Disease Control and Prevention, Atlanta Technology in SARS Discovery Panel 1 Discussion Session II: On the Front Lines Moderated by Scott Hammer Speakers Larry Anderson, Centers for Disease Control and Prevention, Atlanta. Clinical Spectrum of SARS Infection Donald Low, Mt. Sinai Hospital, Toronto Clinical Experience in Toronto Chen Zhu, Shanghai Second Medical University, People's Republic of China. Delivered by Dr. Scott Hammer SARS: An Update from China Panel 2 Discussion Session III: Approaches to Vaccines and Drug Development Moderated by Scott Hammer Speakers David Ho, Aaron Diamond AIDS Research Center, New York Blocking SARS Virus Fusion Frederick Hayden, University of Virginia School of Medicine, Charlottesville Lessons in Interventions for SARS Catherine Laughlin, National Institute of Allergy and Infectious Diseases, Bethesda Status of Drug Screening vs. SARS C. Richter King, GenVec Inc., Gaithersburg, VA Adenovirus Vector Technologies for Vaccines Thomas Monath, Acambis, Cambridge, MA Some Approaches to Vaccine Development Panel 3 Discussion with Richard Colonno (Bristol-Myers Squibb), Michael Dunne (Pfizer) and Emilio Emini (Merck) Session IV: Future Perspectives on Emerging Infections Moderated by Allan Rosenfield Speakers C.J. Peters, University of Texas Medical Branch, Galveston Special Pathogens in Three Cultures Marcelle Layton, NY City Department of Health SARS and Public Health Systems John La Montagne, National Institute of Allergy and Infectious Diseases, Bethesda A View from the Field and the Bridge Panel 4 Discussion

© 2003 Columbia University | Privacy Policy. This Web site is being provided to you for your own use. Any copying or distribution of this Web site is prohibited.